Human CXCL6/GCP-2 Antibody, R&D Systems™

CXCL6/GCP-2

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2), Chemokine alpha 3, CKA-3Granulocyte chemotactic protein 2, GCP-2, GCP2member 6 (granulocytechemotactic protein 2), GCP-2Small-inducible cytokine B6, Small inducible cytokine subfamily B (Cys-X-Cys), member b

Mouse

Protein A or G purified from ascites

RUO

6372

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Western Blot, Neutralization, ELISA

60910

Western Blot 1 ug/mL, Neutralization 8-30 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

P80162

CXCL6

E. coli-derived recombinant human CXCL6/GCP-2 Val40-Asn114 Accession # P80162

500 μg

Primary

Detects human CXCL6/GCP-2 in ELISAs and Western blots. In sandwich immunoassays, less than 0.04% cross-reactivity with recombinant human (rh) NAP-2, rhGRO alpha , rhGRO beta , rhBLC, rhENA-78, recombinant mouse (rm) CXCL6, rmMIP-2, rhIL-8, rhIP-10, rhMIG, rhSDF-1 alpha , and rhSDF-1 beta is observed.

Human

Purified